Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cytokinetics (CYTK) Revenue: 2009-2025

Historic Revenue for Cytokinetics (CYTK) over the last 16 years, with Sep 2025 value amounting to $1.9 million.

  • Cytokinetics' Revenue rose 318.14% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $85.3 million, marking a year-over-year increase of 2549.39%. This contributed to the annual value of $15.0 million for FY2024, which is 99.20% up from last year.
  • As of Q3 2025, Cytokinetics' Revenue stood at $1.9 million, which was down 97.10% from $66.8 million recorded in Q2 2025.
  • In the past 5 years, Cytokinetics' Revenue registered a high of $89.0 million during Q2 2022, and its lowest value of $249,000 during Q2 2024.
  • In the last 3 years, Cytokinetics' Revenue had a median value of $1.6 million in 2025 and averaged $8.6 million.
  • Per our database at Business Quant, Cytokinetics' Revenue slumped by 99.03% in 2023 and then soared by 26,714.86% in 2025.
  • Over the past 5 years, Cytokinetics' Revenue (Quarterly) stood at $54.9 million in 2021, then tumbled by 96.43% to $2.0 million in 2022, then decreased by 14.56% to $1.7 million in 2023, then spiked by 797.13% to $15.0 million in 2024, then surged by 318.14% to $1.9 million in 2025.
  • Its Revenue stands at $1.9 million for Q3 2025, versus $66.8 million for Q2 2025 and $1.6 million for Q1 2025.